INS and Insulin resistance: In conclusion, elevation of MCP-1 production in skeletal muscle and concomitant elevation of plasma MCP-1 lead to enhanced inflammation in skeletal muscle but have no effect on insulin resistance and glucose tolerance in lean and obese mice and do not affect insulin-mediated signalling in skeletal muscle.